Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 21 Oct 2025

Investigation and analysis on the charging status and standard of pharmacy intravenous admixture service in China

in Drugs Outcomes Research and Policies

Jie Cao
Zhou Shu
Jie Li
Dan Wang
Yong-Ning Lyu
Xue-Feng Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1648571

121 views

Original Research

Published on 21 Oct 2025

Immune checkpoint blockers plus chemotherapy as the first-line treatment for advanced or metastatic squamous non-small-cell lung carcinoma: a network meta-analysis and economic evaluation

in Drugs Outcomes Research and Policies

Yitian Lang
Jie Yang
Weican Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1669965

161 views

Perspective

Accepted on 20 Oct 2025

Advances in Clinical Application on Nursing Intervention for Ribavirin-Associated Adverse Events

in Drugs Outcomes Research and Policies

Li-Li Jiang
Qing Wang
Jia-Xin Zhang
Jing-Hui Fan
Jing Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1596007

Original Research

Accepted on 20 Oct 2025

Cost-effectiveness of Edaravone Dexborneol Sublingual Tablet Versus Concentrated Solution for Injection for the Treatment of Acute Ischemic Stroke in China

in Drugs Outcomes Research and Policies

Fan Xie
Yuqiong Lu
Zhuo Yang
Yanlei ZHANG
Yujin Bao
Yun Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1661581

430 views

Original Research

Published on 20 Oct 2025

Cost-effectiveness of iruplinalkib versus crizotinib in first-line anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer patients in China

in Drugs Outcomes Research and Policies

Wanjie Zhang
Yuqiong Lu
Zhanjing Dai
Linning Wang
Yang Zhou
Yun Lu
Feng Chang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1651463

286 views

Original Research

Published on 20 Oct 2025

Remimazolam used for sedation during spinal anesthesia puncture provides faster sedation effect and increase recovery rate compared to midazolam: a randomized controlled trial

in Drugs Outcomes Research and Policies

Peipei Sun
Zhimin Tan
Lianxiong Liang
Jianbo Zhang
Xiaoqiang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1685312

253 views

Original Research

Published on 17 Oct 2025

Low-dose mivacurium facilitates laryngeal mask airway insertion in patients undergoing hysteroscopic surgery: a prospective, single-center, double-blind randomized controlled trial

in Drugs Outcomes Research and Policies

Yingchao Guan
Lizhen Wu
Haochen Wang
Conghui Wang
Yusong Lin
Minghong Ju
Xiaojing Cong
Wen He
Xiaodong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1700175

416 views

Original Research

Accepted on 16 Oct 2025

Ultrasound-guided Thoracic Paravertebral Block Combined with Dexmedetomidine Improves Perioperative Analgesia and Recovery in Medical Thoracoscopy: A Randomized Controlled Trial

in Drugs Outcomes Research and Policies

Jia Nie
Wei Chen
Huanhuan Ma
Liang Fang
Zhimin Deng
Yu Zhang
Hai-ying Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1684199

Original Research

Published on 15 Oct 2025

The value of pharmacist medication therapy management of capecitabine

in Drugs Outcomes Research and Policies

Jing Xue
Chengcui Huang
Xiaorui Liu
Xiaoyu Xie
Xiaoyan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1600976

977 views

Original Research

Published on 14 Oct 2025

Comparison of oxcarbazepine metabolite concentrations measured by EMIT-based Siemens Viva-ProE® system and LC-MS/MS in Chinese patients

in Drugs Outcomes Research and Policies

Ming Chen
Rong-Qi Lin
Yun-Yi Mao
Ying-Bin Huang
Jun-Nan Wu
Xue-Yong Li
Xue-Mei Wu
Yu Cheng
Hong-Qiang Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1697679

899 views

Original Research

Published on 14 Oct 2025

A study on a real-world data-based VTE risk prediction model for lymphoma patients

in Drugs Outcomes Research and Policies

Changli He
Yin Wang
Han Zhang
Sitian Li
Fengjiao Kang
Fengqun Cai
Lizhu Han
Qinan Yin
Gang Li
Xuewu Song

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1691271

761 views

Editorial

Published on 14 Oct 2025

Editorial: Clinical pharmacist service promotes the improvement of medical quality, volume II

in Drugs Outcomes Research and Policies

Hao Li
Jianrong Zhang
Shusen Sun
Wei Luan
Zhi-Chun Gu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1714684

449 views

Methods

Published on 14 Oct 2025

Methodological study protocol for The European Atlas of clinical trials in cancer and haematology

in Drugs Outcomes Research and Policies

Mercè Cases
Rachel Giles
Tamás Ágh
Maria Piggin
Jan Geissler
Monica Racovita
Judit Hagymásy
Lora Ruth Wogu
Ákos Józwiak
Albina Hyseni-Bocolli

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1558556

878 views

Editorial

Published on 13 Oct 2025

Editorial: Translation of health technology reassessment and its outputs of disinvestment, de-implementation and de-adoption of drugs and medical devices in practice-what have we learned?

in Drugs Outcomes Research and Policies

Rosmin Esmail
Nora Ibargoyen-Roteta
Maximilian Otte
Iñaki Gutiérrez-Ibarluzea
Roberta Joppi
Hans-Peter Dauben

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1700196

520 views

Review

Published on 10 Oct 2025

Digital interventions in medication adherence: a narrative review of current evidence and challenges

in Drugs Outcomes Research and Policies

Zoe Moon
Jane Walsh

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1632474

817 views

Review

Published on 10 Oct 2025

Pharmacologic treatment of fibromyalgia: an update

in Drugs Outcomes Research and Policies

Yang Li
Yunshen Li
Shiya Wu
Meijuan Long
Xinyi Chen
Yidan Wang
Jianan Zhao
Bingheng He
Cen Chang
Juan Jiao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1651181

955 views